Characterization of dendritic cells in human and experimental myocarditis.
Rudin PistulliElise AndreasSebastian KönigStefanie DrobnikDaniel KretzschmarIlonka RohmMichael LichtenauerBettina HeideckerMarcus FranzGita MallAtilla YilmazP Christian SchulzePublished in: ESC heart failure (2020)
Circulating DCs are reduced in human myocarditis and accumulate in the inflamed myocardium. MCS-18 treatment reduces DCs in EAM, leading to amelioration of inflammation and left ventricular remodelling during the acute phase of myocarditis. Our data further elucidate the role of DCs and their specific subsets in acute inflammatory cardiomyopathies.
Keyphrases